Cross-reactivity of 4CMenB vaccine-induced antibodies against meningococci belonging to non-B serogroups in Italy

Cross-reactivity of 4CMenB vaccine-induced antibodies against meningococci belonging to non-B serogroups in Italy

The four-component meningococcal serogroup B vaccine (4CMenB) contains antigens present in the majority of meningococci causing invasive meningococcal disease (IMD) and may potentially offer protection against strains belonging to non-B serogroups. This study aimed to evaluate the ability of 4CMenB-...

Full description

Bibliographic Details
Main Authors: Cecilia Fazio, Alessia Biolchi, Arianna Neri, Sara Tomei, Paola Vacca, Luigina Ambrosio, Annapina Palmieri, Elena Mori, Rita La Gaetana, Mariagrazia Pizza, Marzia Monica Giuliani, Laura Serino, Paola Stefanelli
Format: Article
Language:English
Published: Taylor & Francis Group 2021-07-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
neisseria meningitides
4cmenb vaccine
cross-reactivity
non-b serogroups
serum bactericidal assay
italy
Online Access:http://dx.doi.org/10.1080/21645515.2020.1855951

Internet

http://dx.doi.org/10.1080/21645515.2020.1855951

Similar Items